Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
gptkb:drug antineoplastic agent |
| gptkbp:activeIngredient |
gptkb:mitomycin_C
|
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L01DC03
|
| gptkbp:brand |
gptkb:Mutamycin
|
| gptkbp:CASNumber |
50-07-7
|
| gptkbp:contraindication |
pregnancy
|
| gptkbp:derivedFrom |
gptkb:Streptomyces_caespitosus
|
| gptkbp:discoveredIn |
1950s
|
| gptkbp:hasMolecularFormula |
C15H18N4O5
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mutamycin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
DNA crosslinking
|
| gptkbp:molecularWeight |
334.33 g/mol
|
| gptkbp:sideEffect |
nausea
vomiting bone marrow suppression kidney toxicity lung toxicity |
| gptkbp:usedFor |
gptkb:cancer
pancreatic cancer stomach cancer bladder cancer |
| gptkbp:bfsParent |
gptkb:Mitomycin
gptkb:mitomycin_C |
| gptkbp:bfsLayer |
7
|